Impact of Genetic Reduction of NMNAT2 on Chemotherapy-Induced Losses in Cell Viability In Vitro and Peripheral Neuropathy In Vivo

• Richard A. Slivicki,

  Affiliations Program in Neuroscience, Indiana University, Bloomington, IN, United States of America, Department of Psychological and Brain Sciences, Indiana University, Bloomington, IN, United States of America

  ⨯
• Yousuf O. Ali,

  Current address: Department of Psychological and Brain Sciences, Indiana University, Bloomington, IN, United States of America

  Affiliations Department of Psychological and Brain Sciences, Indiana University, Bloomington, IN, United States of America, The Cain Foundation Laboratories, Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, Houston, TX 77030, United States of America, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, United States of America

  ⨯
• Hui-Chen Lu ,

  * E-mail: hclu@indiana.edu (HCL); hohmanna@indiana.edu (AGH)

  Current address: Department of Psychological and Brain Sciences, Indiana University, Bloomington, IN, United States of America

  Affiliations Program in Neuroscience, Indiana University, Bloomington, IN, United States of America, Department of Psychological and Brain Sciences, Indiana University, Bloomington, IN, United States of America, The Cain Foundation Laboratories, Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, Houston, TX 77030, United States of America, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, United States of America

  ⨯
• Andrea G. Hohmann

  * E-mail: hclu@indiana.edu (HCL); hohmanna@indiana.edu (AGH)

  Affiliations Program in Neuroscience, Indiana University, Bloomington, IN, United States of America, Department of Psychological and Brain Sciences, Indiana University, Bloomington, IN, United States of America

  ⨯